Find Funding Opportunities

Notice Availability Administrative Supplements Secondary Analysis Existing Datasets within Rare Diseases Clinical Research Network RDCRN) Explore Outcomes Relevant Rare Diseases Notice Number: NOT-TR-18-019 Key Dates Release Date: April 25, 2018 Related Announcements PA-18-591 Issued National Center Advancing Translational Sciences NCATS) National Heart, Lung, Blood Institute NHLBI) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) Purpose National Center Advancing Translational Science NCATS) announces opportunity investigators relevant active Rare Diseases Clinical Research Consortia RDCRC) Rare Diseases Clinical Research Network RDCRN) U54) submit administrative supplement requests the NIH Parent Funding Opportunity Announcement FOA), Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional)” PA-18-591 .   is vitally important begin use existing RDCRC datasets they intended: through secondary analyses develop new hypotheses Rare Diseases outcomes; such identify particular vulnerabilities specific populations; explore age, sex racial differences may warrant larger studies; discover new treatment/rehabilitation approaches; reveal correlations among outcomes outcome domains can guide future studies.   goal to existing human datasets well-focused secondary analyses investigate novel scientific ideas new models, systems, tools, methods, technologies have potential significant impact biomedical biobehavioral research areas relevant the RDCRN’s mission. RDCRN's mission to foster development scientific knowledge needed enhance health, productivity, independence, quality-of-life individuals Rare Diseases. Program Director(s)/Principal Investigators PIs) strongly encouraged partner Early Stage Investigators ESIs).  Projects must propose collect new data must within scope the current award. Budget Available Funds Budgets limited no than 50K direct costs. Award Project Period Supplement project budget periods limited the remaining FY18 budget period.  be eligible, parent award must active i.e. be an extension period), the research proposed the supplement must accomplished within remaining active budget period started FY18 the existing parent award. earliest anticipated start date July 1, 2018. Review process Administrative Review be conducted a committee NIH RDCRN Program Officers/Program Directors final decisions by funding ICs Page Limit NCATS consider supplements a Research Strategy no than 3 pages. Submitting Application Applicants should begin application stating: application being submitted response NOT-TR-18-019".  additional information, the parent program announcement Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) PA-18-591. Applications these administrative supplements due 5:00 PM local time June 8, 2018. Inquiries Please direct inquiries to: Tiina K. Urv, PhD National Center the Advancement Translational Science NCATS) Telephone: 301-827-2746 Email: urvtiin@mail.nih.gov

Notice Extend Expiration Date Change Receipt Dates PAR-16-458 NINDS Ruth L. Kirschstein National Research Service Award NRSA) Training Postdoctoral Fellows F32)" Notice Number: NOT-NS-18-061 Key Dates Release Date: April 23, 2018 Related Announcements PAR-16-458 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants there be change receipt dates for Funding Opportunity Announcement FOA) PAR-16-458 NINDS Ruth L. Kirschstein National Research Service Award NRSA) Training Postdoctoral Fellows F32)" the expiration date be extended one receipt cycle.  Specifically, receipt dates requests submitted under FOA, PAR-16-458 change August 8, 2018, December 8, 2018, April 8, 2019, August 8, 2019 to June 20, 2018, October 18, 2018, February 15, 2019, and June 19, 2019and additional application due date, October 17, 2019, been added this FOA.  new expiration date this FOA is January 8, 2020. Part 1. Overview Information Key Dates Currently Reads: Application Due Date(s) Standard dates  apply (December 8, 2016, April 8, 2017, August 8, 2017, December 8, 2017, April 8, 2018, August 8, 2018, December 8, 2018, April 8, 2019, August 8, 2019) 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date September 8, 2019 Modified Read: Application Due Date(s) December 8, 2016, April 8, 2017, August 8, 2017, December 8, 2017, April 8, 2018, June 20, 2018, October 18, 2018, February 15, 2019, June 19, 2019, and October 17, 2019 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date January 8, 2020 other aspects this FOA remain same. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke Telephone: 301-496-188 Email: korns@mail.nih.gov

RESCINDED - Notice Change NINDS K99/R00 Eligibility Timeframe Parents Have Child during Standard K99/R00 Application Eligibility Window Notice Number: NOT-NS-18-055 Key Dates Release Date: April 17, 2018 Related Announcements NOT-NS-18-042 - RESCINDED Issued National Institute Neurological Disorders Stroke NINDS) Purpose notice being issued inform recipients NIH rescinded NOT-NS-18-042 Notice Change NINDS K99/R00 Eligibility Timeframe Parents Have Child during Standard K99/R00 Application Eligibility Window" until further review the policy. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov

Notice Change Receipt Dates PA-17-442 Administrative Supplement the NINDS Research Education Program Residents Fellows Neurology, Neurosurgery, Neuropathology, Neuroradiology Emergency Medicine Admin Supplement)" Notice Number: NOT-NS-18-059 Key Dates Release Date: April 13, 2018 Related Announcements PA-17-442 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform potential applicants there be change receipt dates PA-17-442 Administrative Supplements the NINDS Research Education Program Residents Fellows Neurology, Neurosurgery, Neuropathology, Neuroradiology Emergency Medicine R25)". Currently, administrative supplement requests support residents fellows start participation July a given year due October 31 the prior year. Effective immediately, this notice, receipt date these administrative supplement requests be changed October 15 the year prior the July start date intended participation.   Specifically, receipt dates requests submitted under FOA, PA-17-442 change October 31, 2018 October 31, 2019 to October 15, 2018 and October 15, 2019. Part 1. Overview Information Key Dates Currently Reads: Application Due Date(s) October 31, 2017, October 31, 2018, October 31, 2019 5:00 PM local time applicant organization.Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date November 1, 2019   Modified Read:   Application Due Date(s) October 31, 2017, October 15, 2018, and October 15, 2019 by 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Expiration Date October 16, 2019   other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Stephen Korn, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@mail.nih.gov

Alzheimer's Disease its related Dementias AD/ADRD)-focused Administrative supplements NIH grants are focused Alzheimer's disease Notice Number: NOT-AG-18-008 Key Dates Release Date: April 12, 2018 Related Announcements NOT-AI-18-032 NOT-HD-18-010 PA-18-591 Issued National Institute Aging NIA) National Cancer Institute NCI) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) National Institute Dental Craniofacial Research NIDCR) National Institute Deafness Other Communication Disorders NIDCD) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) Fogarty International Center FIC) National Center Complementary Integrative Health NCCIH) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Office Research Women’s Health ORWH) Office Strategic Coordination Common Fund) Purpose participating Institutes Centers ICs) inviting applications expand existing awards these ICs are currently focused Alzheimer’s disease AD) its related dementias ADRD) allow to develop focus AD/ADRD. Active awards project end dates FY 2019 later eligible. award not in terminal cost extension going no cost extension FY2018. administrative supplements work proposed needs be within scope the research training is already supported. Center awards resource awards most likely be able justify supplements they tend have broad content scope. research grants also qualify the current research on related topic such cognitive decline aging, caregiving, health disparities). possible topics include research the biology neurodegeneration, genetics, imaging, on pain perception communication. Topics also include possible connections existing conditions are being studied: such links cardiovascular other diseases, common pathways degeneration, sex gender influences incidence, on previously unidentified risk factors. Also work focuses advances methodology, machine learning other modeling, or on biostatistical tools have application research Alzheimer’s its related dementias be appropriate. NIA developed website shows abstracts Reporter) a sample awards are recognized pursuing AD/ADRD research under current guidelines. site also includes description the categories research NIH currently identifies Alzheimer's disease Alzheimer's disease-related dementias. part the application investigators should submit abstract the proposed research shows relevance AD/ADRD. work include pilot projects, resource development. Investigators should submit applications responses the parent active administrative supplement PA: https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html Individual requests be more 250,000 direct costs exclusive Facilities Administrative costs sub-contracts except the information NHGRI below). Requests be one year support only.  Though supplement requests not limited one per parent grant, will consider substantial additional funding an award beyond scope. Also, before submitting supplement request, principal investigators strongly encouraged contact program officers the Institute, Center Office supporting award discuss whether proposed supplement within scope. Requests must received June 8 funding FY 2018. Institute, Center Office-specific Instructions National Human Genome Research Institute: NHGRI collaboration NIA support supplements NHGRI grants to 500,000 direct cost, support research accomplishes NIA’s research goals described this notice. NHGRI support studies provide generalizable methods knowledge all three scientific areas genome sciences, genomic medicine genomics society. Work proposed supplements must fall within scope the aims the NHGRI grant be supplemented. Investigators encouraged contact NHGRI Scientific Program Officer the grant be supplemented before preparing application, discuss relevance the proposed research the parent grant to Institute's research priorities. National Institute General Medical Sciences: NIGMS’s MIRA program provides support an investigator's overall program research within Institute’s mission, MIRA awardees not eligible this supplement program. Office Strategic Coordination:  Common fund awardees are interested applying should contact Dr. Ravi Basavappa the Office Strategic Coordination Common Fund) before applying. Review process IC conduct administrative reviews applications their IC separately. NIA make funds available up ten awards each the participating ICs is allocating to 20 million this cross-IC program. IC conduct administrative reviews applications their IC separately. NIA make funds available up ten awards each the participating ICs is allocating to 20 million this cross-IC program.   Criteria: 1.      the work proposed within scope the active award? 2.      the work proposed focused Alzheimer’s disease its related dementias? 3.      the work likely stimulate additional activity leading progress AD/ADRD? Inquiries Please direct inquiries to: Robin A. Barr National Institute Aging NIA) Telephone: 301-402-7715 E-mail: BarrR@mail.nih.gov Crystal Wolfrey National Cancer Institute NCI) Telephone: 240-276-6277 E-mail: wolfreyc@mail.nih.gov Martha Flanders National Eye Institute NEI) Telephone: 301-451-2020 E-mail: Martha.flanders@nih.gov Jue Chen, Ph.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0550 Email: jue.chen@nih.gov Bettie Graham National Human Genome Research Institute NHGRI) Telephone: 301-496-7531 E-mail: grahambj@exchange.nih.gov Abraham Bautista National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-9737 E-mail: Bautista@mail.nih.gov Michael Minnicozzi, Ph.D. National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3532 Email: minnicozzim@niaid.nih.gov Melinda Nelson National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-435-5278 E-mail: nelsonm@exchange.nih.gov Randy King National Institute Biomedical Imaging Bioengineering NIBIB) Telephone:301-451-4780 E-mail: randy.king@nih.gov Judith Cooper National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-496-5061 E-mail: cooperj@nidcd.nih.gov Preethi Chander National Institute Dental Craniofacial Research NIDCR) Telephone: 301-827-4620 E-mail: Preethi.chander@nih.gov Luke Stoekel National Institute Diabetes Digestive Kidney Diseases NIDDK) Telephone: 301-741-9223 E-mail: luke.stoeckel@nih.gov Kevin Walton National Institute Drug Abuse NIDA) Telephone: 301-827-5980 kevin.walton@nih.gov Jonathan Hollander National Institute Environmental Health Sciences NIEHS) Telephone: 984-287-3269 E-mail: jonathan.hollander@nih.gov Janna Wehrle National Institute General Medical Sciences NIGMS) Telephone: 301451-6446 E-mail: wehrlej@nigms.nih.gov Jovier Evans National Institute Mental Health NIMH) Telephone: 301-443-1369 E-mail: jevans1@mail.nih.gov Roderick Corriveau National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 E-mail: roderick.corriveau@nih.gov Lois Tully National Institute Nursing Research NINR) Telephone: 301-594-5968 E-mail: lois.tully@nih.gov Adelaida Rosario National Institute Minority Health Health Disparities NIMHD) Telephone: 301-402-1366 E-mail: Adelaida.rosario@nih.gov Hua-Chuan Sim National Library Medicine NLM) Telephone: 301-594-4882 E-mail: simh@mail.nlm.nih.gov Marya Levintova Fogarty International Center FIC) Telephone: 301-496-1653 E-mail: levintovam@mail.nih.gov Dave Clark National Center Complementary Integrative Health NCCIH) Telephone: 301-827-1916 E-mail: dave.clark@nih.gov Stephanie Murphy Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Telephone: 301-435-0744 E-mail: Stephanie.murphy@nih.gov Chyren Hunter Office Research Women’s Health ORWH) Telephone: 301-402-1770 Email: hunterc@mail.nih.gov Ravi Basavappa Office Strategic Coordination OSC) Telephone: 301-435-7204 E-mail: ravikumar.basavappa@nih.gov

Notice NINDS Policy Submission Applications Containing Clinical Trials Notice Number: NOT-NS-18-054 Key Dates Release Date: April 3, 2018 Related Announcements NOT-NS-19-012 NOT-NS-16-034 RESCINDED NOT-NS-18-011  Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to clarify policy submitting investigator-initiated clinical trial applications NINDS. Unless otherwise indicated NIH NINDS Funding Opportunity Announcements FOAs), clinical trials designed answer specific questions the safety, tolerability, efficacy, effectiveness, clinical management, and/or implementation pharmacologic, behavioral, biologic, surgical, device invasive non-invasive) interventions only supported NINDS submitted an NINDS clinical trials-specific FOA.  current list active NINDS clinical trials FOAs available at https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/Clinic….   Applicants strongly advised consult NINDS program staff prior submitting clinical trial application determine appropriate funding opportunity announcement. Inquiries Please direct inquiries to: Peter Gilbert, Sc.M. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-0870 Email: GilbertP@ninds.nih.gov  

Notice NINDS Participation PAR-18-733 Small Research Grants Analyses Data the Gabriella Miller Kids First Data Resource R03 - Clinical Trial Allowed)" Notice Number: NOT-NS-18-051 Key Dates Release Date: March 30, 2018 Related Announcements PAR-18-733 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform potential applicants the National Institute Neurological Disorders Stroke NINDS) participating PAR-18-733 Small Research Grants Analyses Data the Gabriella Miller Kids First Data Resource R03 - Clinical Trial Allowed)". following sections been updated reflect participation NINDS this FOA. Currently Reads: Part 1. Overview Information Components Participating Organizations Kennedy Shriver National Institute Child Health Human Development NICHD) National Heart, Lung, Blood Institute NHLBI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Dental Craniofacial Research NIDCR) Catalog Federal Domestic Assistance CFDA) Number(s) 93.865; 93.837, 93.838, 93.839, 93.233; 93.273; 93.121   Modified Read: Part 1. Overview Information Components Participating Organizations Kennedy Shriver National Institute Child Health Human Development NICHD) National Heart, Lung, Blood Institute NHLBI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Dental Craniofacial Research NIDCR) National Institute Neurological Disorders Stroke NINDS) Catalog Federal Domestic Assistance CFDA) Number(s) 93.865; 93.837, 93.838, 93.839, 93.233; 93.273; 93.121; 93.853  following contacts been added: Section VII. Agency Contacts Scientific/Research Contact(s) Robert Riddle, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5745 Email: rr260c@nih.gov Financial/Grants Management Contact(s) Tijuanna Decoster, Ph.D.  National Institute Neurological Disorders Stroke NINDS)  Telephone: 301-496-9231 E-mail: tijuanna.decoster@nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Robert Riddle, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5745 Email: rr260c@nih.gov

Notice Participation PAR-18-721 Countermeasures Against Chemical Threats CounterACT) Exploratory/Developmental Projects Translational Research R21 Clinical Trial Allowed) Notice Number: NOT-NS-18-053 Key Dates Release Date: March 29, 2018 Related Announcements PAR-18-721 Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) Purpose purpose this Notice to inform potential applicants the National Eye Institute NEI),  National Institute Environmental Health Sciences NIEHS), the National Institute Drug Abuse NIDA) participating PAR-18-721 Countermeasures Against Chemical Threats CounterACT) Exploratory/Developmental Projects Translational Research R21 Clinical Trial Allowed). following sections been updated reflect participation NINDS this FOA. Currently Reads: Part 1. Overview Information Components Participating Organizations National Institute Neurological Disorders Stroke NINDS) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Catalog Federal Domestic Assistance CFDA) Number(s) 93.853; 93.846 Modified Read: Part 1. Overview Information Components Participating Organizations National Institute Neurological Disorders Stroke NINDS) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Eye Institute NEI) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS)   Catalog Federal Domestic Assistance CFDA) Number(s) 93.853; 93.846; 93.867; 93.279; 93.113 following contacts been added: Section VII. Agency Contacts Scientific/Research Contact(s) questions related ocular injury research:  Houmam Araj, Ph.D. National Eye Institute NEI) Telephone: 301-451-2020 Email: arajh@nei.nih.gov questions related pulmonary injury research: Srikanth S. Nadadur, Ph.D. National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-5327 Email: nadadurs@niehs.nih.gov questions related pharmaceutical based agents: Kristopher Bough, Ph.D. National Institute Drug Abuse NIDA) Telephone: 301-443-9800 Email: boughk@nih.gov Financial/Grants Management Contact(s) Karen Robinson Smith National Eye Institute NEI) Telephone: 301-451-2020 Email: kyr@nei.nih.gov Lisa A. Edwards, MBA National Institute Environmental Health Sciences NIEHS) Telephone:  919-541-0751 E-mail: archer@niehs.nih.gov Amy Connolly National Institute Drug Abuse NIDA) Telephone: 301-827-4457 Email: connolla@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Shardell Spriggs, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-443-8189 Email: shardell.spriggs@nih.gov

Notice NINDS BRG, BRP, Translational Neural Devices, BRAIN Initiative: Next Generation Invasive Devices Recording, Modulation the Human Central Nervous System, Smart & Connected Health Program Applications Directed the Treatment Pain Notice Number: NOT-NS-18-052 Key Dates Release Date: March 27, 2018 Related Announcements PAR-18-206 PAR-18-208 RFA-NS-18-011 RFA-NS-18-012 RFA-NS-18-021 RFA-NS-18-022 RFA-NS-18-023 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform potential applicants the National Institute Neurological Disorders Stroke NINDS) Bioengineering Research Grants BRG), Bioengineering Research Partnerships BRP), Translational Neural Devices, BRAIN Initiative: Next Generation Invasive Devices Recording Modulation the Human Central Nervous System, Smart Connected Health Funding Opportunity Announcements an area special interest.  NINDS like accelerate development devices the treatment pain. Investigators strongly encouraged contact appropriate Program Director prior submitting application. Applications be submitted to: PAR-18-206 (BRG), PAR-18-208 (BRP), RFA-NS-18-011 (Translational Neural Devices), RFA-NS-18-012 (Translational Neural Devices - SBIR), RFA-NS-18-021 (BRAIN Initiative), RFA-NS-18-022 (BRAIN Initiative), RFA-NS-18-023 (BRAIN Initiative - SBIR), and NSF-18-541 (Smart Connected Health).      Within BRG BRP programs, NINDS particularly interested bioengineering research advances technologies the potential decrease burden neurological disorders stroke, including pain. Examples areas interest include development validation invasive non-invasive devices, diagnostic/monitoring tools, advanced imaging techniques, computational models, tissue engineering, other innovative methods.   Translational Neural Devices program interested receiving applications translational studies devices treat pain. Translational Neural Devices supports translational activities small clinical studies advance development invasive non-invasive therapeutic, diagnostic devices disorders affect nervous neuromuscular systems. Program activities, including translational bench animal studies, expected lead submission an Investigational Device Exemption IDE) the U.S. Food Drug Administration FDA) Institutional Review Board IRB) application a Non-Significant Risk NSR) study. program also support subsequent small clinical trial collect safety effectiveness data required support marketing application to inform final device design.   BRAIN Initiative: Next Generation Invasive Devices Recording Modulation the Human Central Nervous System program supports translational and/or clinical studies invasive recording and/or stimulating devices treat nervous system disorders, including support the submission an Investigational Device Exemption IDE) a Significant Risk SR) study obtain Institutional Review Board IRB) approval a Non-Significant Risk NSR) study, and/or small clinical trial e.g., Early Feasibility Study). small clinical trial should provide data answer key questions the function final design a device. This final device design require most, not all, the non-clinical testing the path more advanced clinical trials market approval. BRAIN Initiative includes both brain spinal cord this program like encourage translational clinical projects invasive recording and/or stimulating devices treat pain.    Smart Connected Health program https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=504739) an interagency program between Institutes Centers the National Institutes Health NIH) the National Science Foundation NSF) supporting development technologies, analytics models supporting next generation health medical research through high-risk, high-reward advances computer information science, engineering technology, behavior, cognition, robotics imaging. NINDS interested applications next-generation multidisciplinary science encourages research pain a variety areas value health, such networking, pervasive computing, advanced analytics, sensor integration, privacy security, modeling socio-behavioral cognitive processes system process modeling. Inquiries Please direct inquiries to: Nick Langhals, Ph.D. National Institute Neurological Disorders Stroke Telephone: 301-496-1447 Email: nick.langhals@nih.gov Stephanie Fertig, M.B.A. National Institute Neurological Disorders Stroke Telephone: 301-496-1779 Email: fertigs@ninds.nih.gov Michael Oshinsky, Ph.D. National Institute Neurological Disorders Stroke Telephone: 301-496-9964 Email: michael.oshinsky@nih.gov

Notice Change NINDS K99/R00 Eligibility Timeframe Parents Have Child during Standard K99/R00 Application Eligibility Window Notice Number: NOT-NS-18-042 Key Dates Release Date: March 26, 2018 - RESCINDED Related Announcements PA-18-397 PA-18-398 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform community a change NINDS policy regarding eligibility the K99/R00 Transition Independence Award. standard eligibility window the K99/R00 48 months postdoctoral research experience. research experience post-doctorate, whether a postdoctoral fellowship position, any position employment where is expectation research activity, continuation the predoctoral laboratory after leaving graduate program, counts towards K99/R00 eligibility clock. policy applies both new amended applications. Effective immediately publication this notice, NINDS extend K99/R00 eligibility window 8 months individuals who a child who born adopted during standard 48 month eligibility window. extension in addition any official leave absence is taken. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov